$SENS

ROEDER DOUGLAS A purchased $125K of SENS

ROEDER DOUGLAS A purchased 13,953 shares of Senseonics Holdings, Inc. (SENS) at $8.98 ($0.13M total) on 2026-08-19.

Original reporting
SEC EDGAR · ROEDER DOUGLAS A
Published Aug 20, 2026, 10:25 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 20, 2026, 10:30 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$SENS
Bullish
medium confidence
Mentioned
$SENS
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SENSBullishLow
01

Why it matters

The director's purchase modestly supports the stock but is unlikely to move price significantly.

02

Market read

A small insider purchase with limited immediate market impact; useful for tracking insider sentiment.

03

What to watch

Potential upcoming FDA filing or product milestone not disclosed in the filing.

Relevance 5/10Novelty 4/10Timing: filed after market close on 2026-08-20

Background

Form 4 filings disclose insider trades; directors buying shares can be viewed as confidence in the company.

Company-level read

Ticker impact

$SENSBullishMedium confidence
Context

Director Roeder Douglas A purchased 13,953 shares of Senseonics at $8.98, increasing his stake to 171,191 shares.

Expected impact

Potential slight upside as market digests insider purchase.

Evidence & confidence

The purchase size ($125k) is small relative to market cap, but director involvement adds weight.

Market effects

Minimal impact on medical device sector; insider activity is routine.

No regional effect; limited to Senseonics shareholders.

Low global relevance; isolated insider transaction.

Counterpoint

The purchase could be a routine portfolio rebalancing, not a strong bullish signal.

Key entities

  • Senseonics Holdings, Inc.

    Medical device company developing implantable glucose monitoring systems.

  • Roeder Douglas A

    Director of Senseonics who made the purchase.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$SENSHigh

Senseonics Holdings, Inc. (SENS): Results of Operations and Financial Condition

Senseonics Holdings, Inc. (SENS) filed an SEC Form 8-K — Results of Operations and Financial Condition. ​ Senseonics Holdings, Inc. Reports Second Quarter 2026 Financial Results ● Generated second quarter revenue of $14.5 million, an increase of approximately 120% year-over-year ● Raising full-year 2026 revenue guidance to $62 million to $66 million from $60 million to $64 million,